JR

Janardan Ramashankar Yadav

Active Director Designated Partner DIN 09304044
DIN 09304044 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Janardan Ramashankar Yadav

Data last updated:

Janardan Ramashankar Yadav is a Designated Partner at Dhanvantri Medicals & Pharma Llp (since 2021). The company operates in Pharma.

DIN 09304044
Primary Designation Designated Partner
Industry Pharma
First Appointment 02 Sep 2021
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner02 Sep 20212020Active

Board colleagues of Janardan Ramashankar Yadav

NameDINCompanyDesignation
Birendra Baijnath Yadav06743188Dhanvantri Medicals & Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Dhanvantri Medicals & Pharma Llp
Premium access

Shareholding and investment profile for Janardan Ramashankar Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Janardan Ramashankar Yadav

Janardan Ramashankar Yadav currently holds 1 directorship: Dhanvantri Medicals & Pharma Llp (Designated Partner, since 02 Sep 2021).

Janardan Ramashankar Yadav was first appointed on 02 Sep 2021 as Designated Partner at Dhanvantri Medicals & Pharma Llp.

The current boards of Janardan Ramashankar Yadav's companies include Birendra Baijnath Yadav (Dhanvantri Medicals & Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available